{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:28:35Z","timestamp":1784773715204,"version":"3.55.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/WISE-PhD\/LS\/2023\/7"],"award-info":[{"award-number":["DST\/WISE-PhD\/LS\/2023\/7"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/IG\/13\/2023-0756"],"award-info":[{"award-number":["EMDR\/IG\/13\/2023-0756"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Horizon 2020,European Union","award":["SGA-CSA. No. 739570 under FPA No. 664387"],"award-info":[{"award-number":["SGA-CSA. No. 739570 under FPA No. 664387"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04501-6","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T03:00:36Z","timestamp":1744340436000},"page":"3045-3063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advancements in patented technologies for the diagnosis and treatment of chronic kidney disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Poornima","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Chhillar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kukkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manil","family":"Kukkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"4501_CR1","doi-asserted-by":"publisher","first-page":"s03","DOI":"10.1590\/1806-9282.66.s1.3","volume":"66","author":"AL Ammirati","year":"2020","unstructured":"Ammirati AL (2020) Chronic kidney disease. Rev Assoc Med Bras 66:s03\u2013s09","journal-title":"Rev Assoc Med Bras"},{"key":"4501_CR2","unstructured":"Bhushan Raju S, Tej Madipalli R, Corsonello A, Mary Andrade J Prevalence and associated risk factors of chronic kidney disease: A case study within SIME clinics in Quito, Ecuador 2019\u20132021"},{"key":"4501_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D et al (2021) Chronic kidney disease. Lancet 398:786\u2013802","journal-title":"Lancet"},{"key":"4501_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0638-y","author":"S Senanayake","year":"2017","unstructured":"Senanayake S, Gunawardena N, Palihawadana P et al (2017) Symptom burden in chronic kidney disease a population based cross sectional study. BMC Nephrol. https:\/\/doi.org\/10.1186\/s12882-017-0638-y","journal-title":"BMC Nephrol"},{"key":"4501_CR5","unstructured":"Abbasi M (2010) Kidney disorders End-stage renal disease Search date October 2009 Kidney disorders End-stage renal disease. 1\u201316"},{"key":"4501_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2369-13-1","volume":"13","author":"C Kitiyakara","year":"2012","unstructured":"Kitiyakara C, Yamwong S, Vathesatogkit P et al (2012) The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines. BMC Nephrol 13:3\u20135. https:\/\/doi.org\/10.1186\/1471-2369-13-1","journal-title":"BMC Nephrol"},{"key":"4501_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.kint.2018.02.006","volume":"93","author":"KU Eckardt","year":"2018","unstructured":"Eckardt KU, Bansal N, Coresh J et al (2018) Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 93:1281\u20131292. https:\/\/doi.org\/10.1016\/j.kint.2018.02.006","journal-title":"Kidney Int"},{"key":"4501_CR8","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B et al (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034\u20132047. https:\/\/doi.org\/10.1681\/ASN.2005101085","journal-title":"J Am Soc Nephrol"},{"key":"4501_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389:1238\u20131252","journal-title":"Lancet"},{"key":"4501_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.6314\/JIMT.202210_33(5).04","volume":"33","author":"CH Liu","year":"2022","unstructured":"Liu CH, Wang Y, Lee LC et al (2022) Mineralocorticoid receptor antagonists in chronic kidney disease. J Intern Med Taiwan 33:355\u2013364. https:\/\/doi.org\/10.6314\/JIMT.202210_33(5).04","journal-title":"J Intern Med Taiwan"},{"key":"4501_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/ckj\/sfad139","volume":"16","author":"P Sarafidis","year":"2023","unstructured":"Sarafidis P, Iatridi F, Ferro C et al (2023) Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA). Clin Kidney J 16:1885\u20131907. https:\/\/doi.org\/10.1093\/ckj\/sfad139","journal-title":"Clin Kidney J"},{"key":"4501_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/1742271X15627185","author":"SC Tenant","year":"2016","unstructured":"Tenant SC, Gutteridge CM (2016) The clinical use of contrast-enhanced ultrasound in the kidney. Ultrasound. https:\/\/doi.org\/10.1177\/1742271X15627185","journal-title":"Ultrasound"},{"key":"4501_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.49030","volume":"15","author":"AS Chouhan","year":"2023","unstructured":"Chouhan AS, Kaple M, Hingway S (2023) A brief review of diagnostic techniques and clinical management in chronic kidney disease. Cureus 15:1\u201310. https:\/\/doi.org\/10.7759\/cureus.49030","journal-title":"Cureus"},{"key":"4501_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0133417","volume":"10","author":"HJ Chung","year":"2015","unstructured":"Chung HJ, Pellegrini KL, Chung J et al (2015) Nanoparticle detection of urinary markers for point-of-care diagnosis of kidney injury. PLoS ONE 10:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0133417","journal-title":"PLoS ONE"},{"key":"4501_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bioactmat.2020.05.002","volume":"5","author":"Y Ma","year":"2020","unstructured":"Ma Y, Cai F, Li Y et al (2020) A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease. Bioact Mater 5:732\u2013743. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.05.002.","journal-title":"Bioact Mater"},{"key":"4501_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/app11209656","volume":"11","author":"SM Dizaj","year":"2021","unstructured":"Dizaj SM, Eftekhari A, Mammadova S et al (2021) Nanomaterials for chronic kidney disease detection. Appl Sci 11:1\u201311. https:\/\/doi.org\/10.3390\/app11209656","journal-title":"Appl Sci"},{"key":"4501_CR17","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1039\/d0qm01009j","volume":"5","author":"B Yao","year":"2021","unstructured":"Yao B, Giel MC, Hong Y (2021) Detection of kidney disease biomarkers based on fluorescence technology. Mater Chem Front 5:2124\u20132142. https:\/\/doi.org\/10.1039\/d0qm01009j","journal-title":"Mater Chem Front"},{"key":"4501_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2021.817974","volume":"12","author":"JPJ Merlin","year":"2022","unstructured":"Merlin JPJ, Li X (2022) Role of nanotechnology and their perspectives in the treatment of kidney diseases. Front Genet 12:1\u201322. https:\/\/doi.org\/10.3389\/fgene.2021.817974","journal-title":"Front Genet"},{"key":"4501_CR19","doi-asserted-by":"publisher","unstructured":"Yang K, Shang Y, Yang N, Pan S, Jin J, He Q (2023) Application of nanoparticles in the diagnosis and treatment of chronic kidney disease. Front. Med. 10:1132355. https:\/\/doi.org\/10.3389\/fmed.2023.1132355","DOI":"10.3389\/fmed.2023.1132355"},{"key":"4501_CR20","doi-asserted-by":"crossref","unstructured":"Bhatt P (2024) A brief review on the nanomaterials-based detection of CKD biomarkers. 02004:1\u20137","DOI":"10.1051\/e3sconf\/202450902004"},{"key":"4501_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2024.117572","author":"P Bhatt","year":"2024","unstructured":"Bhatt P, Kukkar D, Kim K-H (2024) Fluorescent nanomaterials for the detection of chronic kidney disease. TrAC Trends Anal Chem. https:\/\/doi.org\/10.1016\/j.trac.2024.117572","journal-title":"TrAC Trends Anal Chem"},{"key":"4501_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0132482","volume":"10","author":"JA Tumlin","year":"2015","unstructured":"Tumlin JA, Galphin CM, Tolwani AJ et al (2015) A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS ONE 10:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0132482","journal-title":"PLoS ONE"},{"key":"4501_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21165846","volume":"21","author":"M Provenzano","year":"2020","unstructured":"Provenzano M, Rotundo S, Chiodini P et al (2020) Contribution of predictive and prognostic biomarkers to clinical research on chronic kidney disease. Int J Mol Sci 21:1\u201325. https:\/\/doi.org\/10.3390\/ijms21165846","journal-title":"Int J Mol Sci"},{"key":"4501_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22010043","volume":"22","author":"I Lousa","year":"2021","unstructured":"Lousa I, Reis F, Beir\u00e3o I et al (2021) New potential biomarkers for chronic kidney disease management\u2014A review of the literature. Int J Mol Sci 22:1\u201337. https:\/\/doi.org\/10.3390\/ijms22010043","journal-title":"Int J Mol Sci"},{"key":"4501_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MNH.0000000000000735","volume":"30","author":"A Zabetian","year":"2021","unstructured":"Zabetian A, Coca SG (2021) Plasma and urine biomarkers in chronic kidney disease: closer to clinical application. Curr Opin Nephrol Hypertens 30:531\u2013537","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4501_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.785375","author":"Z Yan","year":"2021","unstructured":"Yan Z, Wang G, Shi X (2021) Advances in the progression and prognosis biomarkers of chronic kidney disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.785375","journal-title":"Front Pharmacol"},{"key":"4501_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000530918","volume":"148","author":"I Sandokji","year":"2024","unstructured":"Sandokji I, Xu Y, Denburg M et al (2024) Current and novel biomarkers of progression risk in children with chronic kidney disease. Nephron 148:1\u201310. https:\/\/doi.org\/10.1159\/000530918","journal-title":"Nephron"},{"key":"4501_CR28","doi-asserted-by":"publisher","unstructured":"Mizdrak M, Kumri\u0107 M, Kurir TT, Bo\u017ei\u0107 J (2022) Emerging Biomarkers for Early Detection of Chronic Kidney Disease. J Pers Med. 2022 Mar 31;12(4):548. https:\/\/doi.org\/10.3390\/jpm12040548","DOI":"10.3390\/jpm12040548"},{"key":"4501_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ebiom.2023.104635","volume":"93","author":"F Bienaim\u00e9","year":"2023","unstructured":"Bienaim\u00e9 F, Muorah M, Metzger M et al (2023) Combining robust urine biomarkers to assess chronic kidney disease progression. eBioMedicine 93:1\u201314. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104635","journal-title":"eBioMedicine"},{"key":"4501_CR30","first-page":"170","volume":"2","author":"S Gowda","year":"2010","unstructured":"Gowda S, Desai PB, Kulkarni SS et al (2010) Markers of renal function tests. N Am J Med Sci 2:170\u2013173","journal-title":"N Am J Med Sci"},{"key":"4501_CR31","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2022\/59964.17284","author":"M Thalquotra","year":"2022","unstructured":"Thalquotra M, Brar GK, Ahi RS (2022) Association of serum beta-trace protein levels in patients with chronic kidney disease: a case-control study. J Clin Diagn Res. https:\/\/doi.org\/10.7860\/jcdr\/2022\/59964.17284","journal-title":"J Clin Diagn Res"},{"key":"4501_CR32","unstructured":"Kamal A (2014) Estimation of blood urea (BUN) and serum creatinine level in patients of renal disorder. Indian J Fundam Appl Life Sci 4(4):199-202"},{"key":"4501_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/9781119714521.ch8","author":"SM Dial","year":"2023","unstructured":"Dial SM (2023) Blood urea nitrogen. Low-Cost Vet Clin Diagn. https:\/\/doi.org\/10.1002\/9781119714521.ch8","journal-title":"Low-Cost Vet Clin Diagn"},{"key":"4501_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-47109-5","volume":"13","author":"K Xue","year":"2023","unstructured":"Xue K, Xing S (2023) Blood urea nitrogen concentration is associated with severe abdominal aortic calcification in adults: a cross-sectional investigation. Sci Rep 13:1\u20138. https:\/\/doi.org\/10.1038\/s41598-023-47109-5","journal-title":"Sci Rep"},{"key":"4501_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/00365510802145059","volume":"68","author":"JV Bonventre","year":"2008","unstructured":"Bonventre JV (2008) Kidney injury molecule-1 (KIM-1): A specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest 68:78\u201383. https:\/\/doi.org\/10.1080\/00365510802145059","journal-title":"Scand J Clin Lab Invest"},{"key":"4501_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-4617-0.00033-9","author":"E Macedo","year":"2013","unstructured":"Macedo E, Mehta RL (2013) Clinical approach to the diagnosis of acute kidney injury. Natl Kidney Found Prim Kidney Dis. https:\/\/doi.org\/10.1016\/B978-1-4557-4617-0.00033-9","journal-title":"Natl Kidney Found Prim Kidney Dis"},{"key":"4501_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/00325481.2023.2256208","volume":"135","author":"T Hannedouche","year":"2023","unstructured":"Hannedouche T, Rossignol P, Darmon P et al (2023) Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations. Postgrad Med 135:633\u2013645. https:\/\/doi.org\/10.1080\/00325481.2023.2256208","journal-title":"Postgrad Med"},{"key":"4501_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31083\/j.rcm2501001","volume":"25","author":"C Abenavoli","year":"2024","unstructured":"Abenavoli C, Provenzano M, Ksiazek SH et al (2024) Role of estimated glomerular filtration rate in clinical research: the never-ending matter. Rev Cardiovasc Med 25:1\u201314. https:\/\/doi.org\/10.31083\/j.rcm2501001","journal-title":"Rev Cardiovasc Med"},{"key":"4501_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5662\/wjm.v7.i3.73","volume":"7","author":"A Alaini","year":"2017","unstructured":"Alaini A, Malhotra D, Rondon-Berrios H et al (2017) Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate. World J Methodol 7:73\u201392. https:\/\/doi.org\/10.5662\/wjm.v7.i3.73","journal-title":"World J Methodol"},{"key":"4501_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/icb.2014.121","volume":"93","author":"Y Xu","year":"2015","unstructured":"Xu Y, Ding Y, Li X, Wu X (2015) Cystatin C is a disease-associated protein subject to multiple regulation. Immunol Cell Biol 93:442\u2013451. https:\/\/doi.org\/10.1038\/icb.2014.121","journal-title":"Immunol Cell Biol"},{"key":"4501_CR41","first-page":"361","volume":"19","author":"JS Al Wakeel","year":"2008","unstructured":"Al Wakeel JS, Memon NA, Chaudhary AR et al (2008) Normal reference levels of serum cystatin C in Saudi adults. Saudi J Kidney Dis Transpl 19:361\u2013370","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"4501_CR42","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.34067\/KID.0003202022","volume":"3","author":"DC Chen","year":"2022","unstructured":"Chen DC, Potok OA, Rifkin D, Estrella MM (2022) Advantages, limitations, and clinical considerations in using cystatin C to Estimate GFR. Kidney360 3:1807\u20131814. https:\/\/doi.org\/10.34067\/KID.0003202022","journal-title":"Kidney360"},{"key":"4501_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9010205","volume":"9","author":"J Wajda","year":"2020","unstructured":"Wajda J, Dumnicka P, Sporek M et al (2020) Does beta-trace protein (BTP) outperform cystatin C as a diagnostic marker of acute kidney injury complicating the early phase of acute pancreatitis? J Clin Med 9:1\u201314. https:\/\/doi.org\/10.3390\/jcm9010205","journal-title":"J Clin Med"},{"key":"4501_CR44","doi-asserted-by":"publisher","first-page":"382918","DOI":"10.1155\/2015\/382918","volume":"2015","author":"C Giordano","year":"2015","unstructured":"Giordano C, Karasik O, King-Morris K, Asmar A (2015) Uric acid as a marker of kidney disease: review of the current literature. Dis Mark 2015:382918. https:\/\/doi.org\/10.1155\/2015\/382918","journal-title":"Dis Mark"},{"key":"4501_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.xkme.2019.11.007","volume":"2","author":"L Perrenoud","year":"2020","unstructured":"Perrenoud L, Kruse NT, Andrews E et al (2020) Uric acid lowering and biomarkers of kidney damage in CKD stage 3: a post hoc analysis of a randomized clinical trial. Kidney Med 2:155\u2013161. https:\/\/doi.org\/10.1016\/j.xkme.2019.11.007","journal-title":"Kidney Med"},{"key":"4501_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","volume":"61","author":"DI Jalal","year":"2013","unstructured":"Jalal DI, Chonchol M, Chen W, Targher G (2013) Uric acid as a target of therapy in CKD. Am J Kidney Dis 61:134\u2013146. https:\/\/doi.org\/10.1053\/j.ajkd.2012.07.021","journal-title":"Am J Kidney Dis"},{"key":"4501_CR47","first-page":"e32188","volume":"14","author":"V Vasilkova","year":"2024","unstructured":"Vasilkova V, Pchelin I, Bayrasheva V et al (2024) The role of inflammatory markers and growth factors in progression of chronic kidney disease in patients with diabetes mellitus. J Ren Inj Prev 14:e32188\u2013e32188","journal-title":"J Ren Inj Prev"},{"key":"4501_CR48","doi-asserted-by":"publisher","first-page":"1098612X2412349","DOI":"10.1177\/1098612X241234984","volume":"26","author":"S Summers","year":"2024","unstructured":"Summers S, Michael HT, Szlosek D, Mack R (2024) Blood fibroblast growth factor 23 concentration in cats with and without chronic kidney disease: a scoping review. J Feline Med Surg 26:1098612X241234984","journal-title":"J Feline Med Surg"},{"key":"4501_CR49","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00431-024-05496-5","volume":"183","author":"E Kostopoulou","year":"2024","unstructured":"Kostopoulou E, Kalavrizioti D, Davoulou P et al (2024) Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study. Eur J Pediatr 183:2383\u20132389","journal-title":"Eur J Pediatr"},{"key":"4501_CR50","doi-asserted-by":"publisher","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","volume":"12","author":"LJH Rasmussen","year":"2021","unstructured":"Rasmussen LJH, Petersen JEV, Eugen-Olsen J (2021) Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation. Front Immunol 12:780641","journal-title":"Front Immunol"},{"key":"4501_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/10408363.2016.1269310","volume":"54","author":"S Desmedt","year":"2017","unstructured":"Desmedt S, Desmedt V, Delanghe JR et al (2017) The intriguing role of soluble urokinase receptor in inflammatory diseases. Crit Rev Clin Lab Sci 54:117\u2013133","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4501_CR52","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.21608\/ejhm.2022.256323","volume":"89","author":"ME Ibrahim","year":"2022","unstructured":"Ibrahim ME, Badr MIM, El-Hassib A et al (2022) Proenkephalin A119\u2013159 as a biomarker of acute kidney injury in ICU patients with sepsis. Egypt J Hosp Med 89:4197\u20134204","journal-title":"Egypt J Hosp Med"},{"key":"4501_CR53","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ejvs.2024.01.084","volume":"67","author":"P Walczak-Wieteska","year":"2024","unstructured":"Walczak-Wieteska P, Zuzda K, Szcz\u0119sna K et al (2024) Proenkephalin A 119\u2013159, a possible early biomarker of acute kidney injury in complex endovascular aortic repair: a single centre observational, cross sectional study. Eur J Vasc Endovasc Surg 67:1023\u20131024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"4501_CR54","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1681\/asn.2010060614","volume":"21","author":"B Kestenbaum","year":"2010","unstructured":"Kestenbaum B, de Boer IH (2010) Urine albumin-to-creatinine ratio. J Am Soc Nephrol 21:1243\u20131244. https:\/\/doi.org\/10.1681\/asn.2010060614","journal-title":"J Am Soc Nephrol"},{"key":"4501_CR55","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211003683","author":"EA Christofides","year":"2021","unstructured":"Christofides EA, Desai N (2021) Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J Prim Care Commun Heal. https:\/\/doi.org\/10.1177\/21501327211003683","journal-title":"J Prim Care Commun Heal"},{"key":"4501_CR56","doi-asserted-by":"publisher","DOI":"10.5301\/pocj.5000194","author":"MA Cassia","year":"2016","unstructured":"Cassia MA, Pozzi FE, Bascap\u00e8 S et al (2016) Proteinuria and albuminuria at point of care. Nephrol @ Point Care. https:\/\/doi.org\/10.5301\/pocj.5000194","journal-title":"Nephrol @ Point Care"},{"key":"4501_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7150\/ijbs.5.128","volume":"5","author":"S Chaturvedi","year":"2009","unstructured":"Chaturvedi S, Farmer T, Kapke GF (2009) Assay Validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci 5:128\u2013134. https:\/\/doi.org\/10.7150\/ijbs.5.128","journal-title":"Int J Biol Sci"},{"key":"4501_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2022.960059","volume":"13","author":"C Zou","year":"2022","unstructured":"Zou C, Wang C, Lu L (2022) Advances in the study of subclinical AKI biomarkers. Front Physiol 13:1\u201315. https:\/\/doi.org\/10.3389\/fphys.2022.960059","journal-title":"Front Physiol"},{"key":"4501_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/854070","author":"B Medi\u0107","year":"2015","unstructured":"Medi\u0107 B, Rov\u010danin B, Basta Jovanovi\u0107 G et al (2015) Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/854070","journal-title":"Biomed Res Int"},{"key":"4501_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.ajkd.2014.06.038","volume":"65","author":"CA White","year":"2015","unstructured":"White CA, Ghazan-Shahi S, Adams MA (2015) \u0392-trace protein: A marker of GFR and other biological pathways. Am J Kidney Dis 65:131\u2013146. https:\/\/doi.org\/10.1053\/j.ajkd.2014.06.038","journal-title":"Am J Kidney Dis"},{"key":"4501_CR61","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000514173","volume":"46","author":"K Leyssens","year":"2021","unstructured":"Leyssens K, Van Regenmortel N, Roelant E et al (2021) Beta-trace protein as a potential marker of acute kidney injury: A pilot study. Kidney Blood Press Res 46:185\u2013195. https:\/\/doi.org\/10.1159\/000514173","journal-title":"Kidney Blood Press Res"},{"key":"4501_CR62","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2215\/CJN.08870812","volume":"8","author":"E Orenes-Pi\u00f1ero","year":"2013","unstructured":"Orenes-Pi\u00f1ero E, Manzano-Fern\u00e1ndez S, L\u00f3pez-Cuenca \u00c1 et al (2013) \u03b2-trace protein: From GFR marker to cardiovascular risk predictor. Clin J Am Soc Nephrol 8:873\u2013881. https:\/\/doi.org\/10.2215\/CJN.08870812","journal-title":"Clin J Am Soc Nephrol"},{"key":"4501_CR63","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","volume":"52","author":"D Bolignano","year":"2008","unstructured":"Bolignano D, Donato V, Coppolino G et al (2008) Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J kidney Dis Off J Natl Kidney Found 52:595\u2013605. https:\/\/doi.org\/10.1053\/j.ajkd.2008.01.020","journal-title":"Am J kidney Dis Off J Natl Kidney Found"},{"key":"4501_CR64","doi-asserted-by":"publisher","first-page":"745","DOI":"10.5812\/numonthly.9385","volume":"5","author":"Z Rostami","year":"2013","unstructured":"Rostami Z, Nikpoor M, Einollahi B (2013) Urinary neutrophil gelatinase associated lipocalin (NGAL) for early diagnosis of acute kidney injury in renal transplant recipients. Nephrourol Mon 5:745\u2013752. https:\/\/doi.org\/10.5812\/numonthly.9385","journal-title":"Nephrourol Mon"},{"key":"4501_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-023-03120-6","volume":"24","author":"M Danquah","year":"2023","unstructured":"Danquah M, Owiredu WKBA, Jnr BAE et al (2023) Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal failure in hypertensives: a case\u2013control study in a regional hospital in Ghana. BMC Nephrol 24:1\u201310. https:\/\/doi.org\/10.1186\/s12882-023-03120-6","journal-title":"BMC Nephrol"},{"key":"4501_CR66","unstructured":"Vinay Kumar, Navakant BHAT ,Nikhila KASHYAP DM Device and method for detecting creatinine and albumin to creatinine ratio. PCT Int. Appl. PCT\/IB2016\/050311."},{"key":"4501_CR67","unstructured":"Hossam Haick, Haifa (IL); Ophir Marom ZY (IL) (2017) (12) United States Patent. 2:"},{"key":"4501_CR68","unstructured":"GALA KMucharZForoncewiczlPaczeknKratak (2023) Use of serum 2-cysteine peroxiredoxins (2-cys-prdx) as biomarkers of chronic kidney diseases (ckd) such as lupus nephritis (ln), iga nephropathy (igan) and autosomal-dominant polycystic kidney disease (adpkd) useful for diagnosing, these diseases and meth"},{"key":"4501_CR69","unstructured":"Fitzgerald IMRichardsonjLP Kidney disease biomarker"},{"key":"4501_CR70","unstructured":"Hossein Abdul Tehrani, Tehran (IR )\u202f; Alieh Gholaminejad I( I) (2005) V , y > \u03b4. 2005:1\u201312"},{"key":"4501_CR71","unstructured":"Spain STLPMLMELBD (2024) Methods and devices for detecting diabetic nephropathy and associated disorders"},{"key":"#cr-split#-4501_CR72.1","unstructured":"SJCI (2017) ( 12 ) Patent Application Publication (10) Pub . No .: US 2017 \/ 0116693 A1 Complete Patent Application Publication. 1:2015-2018"},{"key":"#cr-split#-4501_CR72.2","unstructured":"Christos CHATZIANTONIOU, Paris (FR); Jean-Claude DUSSAULE P (FR); SJCI (2017) ( 12 ) Patent Application Publication"},{"key":"#cr-split#-4501_CR72.3","unstructured":"(10) Pub . No .: US 2017 \/ 0116693 A1 Complete Patent Application Publication. 1:2015-2018"},{"key":"4501_CR73","unstructured":"Masanori Yoshida, Akita ( JP )\u202f; Mari Dezawa S( J) (2013) ( 12 ) United States Patent. 2:"},{"key":"4501_CR74","unstructured":"Anna Maria LANGKILDE S(S) (2022) A to"},{"key":"4501_CR75","unstructured":"Deepak Jain, Classification P (2018) Thai maitint a un altri con una di qualitation"},{"key":"4501_CR76","unstructured":"Town W (2022) Patent Application Publication (10) Pub. No : US 2022\/0193022 A1. 2022:"},{"key":"4501_CR77","unstructured":"YNU YU (2022) Copper peroxide\/hydrogen bond organic framework nano material, probe thereof and kit for detecting lipocalin-2, Patent application no. CN114230804B, https:\/\/patents.google.com\/patent\/CN114230804B."},{"key":"4501_CR78","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","volume":"37","author":"GS Ginsburg","year":"2018","unstructured":"Ginsburg GS, Phillips KA (2018) Precision medicine: From science to value. Health Aff 37:694\u2013701. https:\/\/doi.org\/10.1377\/hlthaff.2017.1624","journal-title":"Health Aff"},{"key":"4501_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab045","author":"SC Tye","year":"2021","unstructured":"Tye SC, Denig P, Heerspink HJL (2021) Precision medicine approaches for diabetic kidney disease\u202f: opportunities and challenges. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfab045","journal-title":"Nephrol Dial Transpl"},{"key":"4501_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061326","author":"FA Yousef Yengej","year":"2020","unstructured":"Yousef Yengej FA, Jansen J, Rookmaaker MB et al (2020) Kidney organoids and tubuloids. Cells. https:\/\/doi.org\/10.3390\/cells9061326","journal-title":"Cells"},{"key":"4501_CR81","doi-asserted-by":"publisher","unstructured":"Romero-Guevara R, Ioannides A, Xinaris C (2020). Kidney Organoids as Disease Models: Strengths, Weaknesses and Perspectives. Front Physiol. 2020 Nov 4;11:563981. https:\/\/doi.org\/10.3389\/fphys.2020.563981","DOI":"10.3389\/fphys.2020.563981"},{"key":"4501_CR82","doi-asserted-by":"publisher","unstructured":"Krisanapan P, Tangpanithandee S, Thongprayoon C, Pattharanitima P, Cheungpasitporn W (2018) Revolutionizing Chronic Kidney Disease Management with Machine Learning and Artificial Intelligence. J Clin Med. 2023 Apr 21;12(8):3018. https:\/\/doi.org\/10.3390\/jcm12083018","DOI":"10.3390\/jcm12083018"},{"key":"4501_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diagnostics14040397","volume":"14","author":"CC Wu","year":"2024","unstructured":"Wu CC, Islam MM, Poly TN, Weng YC (2024) Artificial intelligence in kidney disease: a comprehensive study and directions for future research. Diagnostics 14:1\u201315. https:\/\/doi.org\/10.3390\/diagnostics14040397","journal-title":"Diagnostics"},{"key":"4501_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010116","author":"V Singh","year":"2022","unstructured":"Singh V, Asari VK, Rajasekaran R (2022) A deep neural network for early detection and prediction of chronic kidney disease. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics12010116","journal-title":"Diagnostics"},{"key":"4501_CR85","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2337\/db20-499-P","volume":"69","author":"L Chan","year":"2020","unstructured":"Chan L, Nadkarni GN, Fleming F et al (2020) 499-P: clinical validation of an AI-enabled prognostic test (KidneyintelX) to accurately predict rapid kidney function decline in patients with type 2 diabetic kidney disease. Diabetes 69:499. https:\/\/doi.org\/10.2337\/db20-499-P","journal-title":"Diabetes"},{"key":"4501_CR86","unstructured":"Arifuzzaman M, Ahmed I, Chowdhury MJU, et al (2024) A Novel Ensemble-Based Deep Learning Model with Explainable AI for Accurate Kidney Disease Diagnosis. arXiv Prepr arXiv241209472"},{"key":"4501_CR87","unstructured":"Veeva (2024) Decision Impact Trial of KidneyIntelX"},{"key":"4501_CR88","doi-asserted-by":"publisher","first-page":"970","DOI":"10.7150\/ijms.42078","volume":"17","author":"Q Yuan","year":"2020","unstructured":"Yuan Q, Zhang H, Deng T et al (2020) Role of artificial intelligence in kidney disease. Int J Med Sci 17:970\u2013984. https:\/\/doi.org\/10.7150\/ijms.42078","journal-title":"Int J Med Sci"},{"key":"4501_CR89","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MNH.0000000000000604","volume":"29","author":"L Chan","year":"2020","unstructured":"Chan L, Vaid A, Nadkarni GN (2020) Applications of machine learning methods in kidney disease: hope or hype? Curr Opin Nephrol Hypertens 29:319\u2013326. https:\/\/doi.org\/10.1097\/MNH.0000000000000604","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4501_CR90","doi-asserted-by":"publisher","DOI":"10.1039\/D3NA00462G","author":"VA Online","year":"2023","unstructured":"Online VA (2023) Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects. Nanoscale Adv. https:\/\/doi.org\/10.1039\/D3NA00462G","journal-title":"Nanoscale Adv"},{"key":"4501_CR91","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bioactmat.2024.03.014","volume":"37","author":"S Shang","year":"2024","unstructured":"Shang S, Li X, Wang H et al (2024) Targeted therapy of kidney disease with nanoparticle drug delivery materials. Bioact Mater 37:206\u2013221. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.03.014","journal-title":"Bioact Mater"},{"key":"4501_CR92","doi-asserted-by":"publisher","first-page":"101534","DOI":"10.1016\/j.mtbio.2025.101534","volume":"31","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang C (2025) Nanomaterials for targeted therapy of kidney diseases: Strategies and advances. Mater Today Bio 31:101534. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101534","journal-title":"Mater Today Bio"},{"key":"4501_CR93","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000337052","volume":"177","author":"Y Kanno","year":"2012","unstructured":"Kanno Y, Miki N (2012) Development of a nanotechnology-based dialysis device. Home Dial Japan Contemp Status 177:178\u2013183. https:\/\/doi.org\/10.1159\/000337052","journal-title":"Home Dial Japan Contemp Status"},{"key":"4501_CR94","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00467-014-2968-3","volume":"30","author":"A Davenport","year":"2015","unstructured":"Davenport A (2015) Portable and wearable dialysis devices for the treatment of patients with end-stage kidney failure: Wishful thinking or just over the horizon? Pediatr Nephrol 30:2053\u20132060. https:\/\/doi.org\/10.1007\/s00467-014-2968-3","journal-title":"Pediatr Nephrol"},{"key":"4501_CR95","doi-asserted-by":"publisher","first-page":"443","DOI":"10.20892\/j.issn.2095-3941.2016.0075","volume":"13","author":"R Yao","year":"2016","unstructured":"Yao R, Xu G, Mao SS et al (2016) Three-dimensional printing: review of application in medicine and hepatic surgery. Cancer Biol Med 13:443\u2013451. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0075","journal-title":"Cancer Biol Med"},{"key":"4501_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1088592","author":"S Dai","year":"2022","unstructured":"Dai S, Wang Q, Jiang Z et al (2022) Application of three-dimensional printing technology in renal diseases. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.1088592","journal-title":"Front Med"},{"key":"4501_CR97","doi-asserted-by":"publisher","DOI":"10.1590\/1518-8345.6824.4050","author":"OAE de Almeida","year":"2023","unstructured":"de Almeida OAE, de Lima MEF, Santos WS, Silva BLM (2023) Telehealth strategies in the care of people with chronic kidney disease: integrative review. Rev Lat Am Enfermagem. https:\/\/doi.org\/10.1590\/1518-8345.6824.4050","journal-title":"Rev Lat Am Enfermagem"},{"key":"4501_CR98","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ekir.2021.02.016","volume":"6","author":"S Lambooy","year":"2021","unstructured":"Lambooy S, Krishnasamy R, Pollock A et al (2021) Telemedicine for outpatient care of kidney transplant and CKD patients. Kidney Int Rep 6:1265\u20131272. https:\/\/doi.org\/10.1016\/j.ekir.2021.02.016","journal-title":"Kidney Int Rep"},{"key":"4501_CR99","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s40620-024-02023-5","volume":"37","author":"S Jayousi","year":"2024","unstructured":"Jayousi S, Cinelli M, Bigazzi R, Bianchi S (2024) Telemedicine for home-based management of patients with chronic kidney diseases and comorbidities in Tuscany North-west region: a pilot study protocol (telemechron study). J Nephrol 37:2403\u20132407. https:\/\/doi.org\/10.1007\/s40620-024-02023-5","journal-title":"J Nephrol"},{"key":"4501_CR100","doi-asserted-by":"publisher","unstructured":"Wu CC, Islam MM, Poly TN, Weng YC (2024) Artificial Intelligence in Kidney Disease: A Comprehensive Study and Directions for Future Research. Diagnostics (Basel). 2024 Feb 12;14(4):397. https:\/\/doi.org\/10.3390\/diagnostics14040397.","DOI":"10.3390\/diagnostics14040397"},{"key":"4501_CR101","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijin.2022.05.002","volume":"3","author":"M Javaid","year":"2022","unstructured":"Javaid M, Haleem A, Pratap Singh R et al (2022) Significance of machine learning in healthcare: features pillars and applications. Int J Intell Netw 3:58\u201373. https:\/\/doi.org\/10.1016\/j.ijin.2022.05.002","journal-title":"Int J Intell Netw"},{"key":"4501_CR102","doi-asserted-by":"publisher","first-page":"e54206","DOI":"10.2196\/54206","volume":"26","author":"J Ma","year":"2024","unstructured":"Ma J, Wang J, Ying J et al (2024) Long-term efficacy of an ai-based health coaching mobile app in slowing the progression of nondialysis-dependent chronic kidney disease: retrospective cohort study. J Med Internet Res 26:e54206. https:\/\/doi.org\/10.2196\/54206","journal-title":"J Med Internet Res"},{"key":"4501_CR103","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.xkme.2022.100435","volume":"4","author":"P Devarajan","year":"2022","unstructured":"Devarajan P, Chertow GM, Susztak K et al (2022) Emerging role of clinical genetics in CKD. Kidney Med 4:100435. https:\/\/doi.org\/10.1016\/j.xkme.2022.100435","journal-title":"Kidney Med"},{"key":"4501_CR104","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2215\/CJN.00020120","volume":"15","author":"A Tin","year":"2020","unstructured":"Tin A, K\u00f6ttgen A (2020) Genome-wide association studies of CKD and related traits. Clin J Am Soc Nephrol 15:1643\u20131656. https:\/\/doi.org\/10.2215\/CJN.00020120","journal-title":"Clin J Am Soc Nephrol"},{"key":"4501_CR105","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1681\/ASN.2020111599","volume":"32","author":"Z Yu","year":"2021","unstructured":"Yu Z, Jin J, Tin A et al (2021) Polygenic risk scores for kidney function and their associations with circulating proteome, and incident kidney diseases. J Am Soc Nephrol 32:3161\u20133173. https:\/\/doi.org\/10.1681\/ASN.2020111599","journal-title":"J Am Soc Nephrol"},{"key":"4501_CR106","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s43162-024-00341-5","volume":"36","author":"N Aderinto","year":"2024","unstructured":"Aderinto N, Olatunji G, Kokori E et al (2024) Genomic insights into renal diseases: advancements and implications. Egypt J Intern Med 36:73. https:\/\/doi.org\/10.1186\/s43162-024-00341-5","journal-title":"Egypt J Intern Med"},{"key":"4501_CR107","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","volume":"101","author":"A K\u00f6ttgen","year":"2022","unstructured":"K\u00f6ttgen A, Cornec-Le Gall E, Halbritter J et al (2022) Genetics in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) Controversies Conference. Kidney Int 101:1126\u20131141. https:\/\/doi.org\/10.1016\/j.kint.2022.03.019","journal-title":"Kidney Int"},{"key":"4501_CR108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s44337-024-00160-1","volume":"1","author":"IJ Ogieuhi","year":"2024","unstructured":"Ogieuhi IJ, Olatunji G, Kokori E et al (2024) Efficacy and safety of Vadadustat in the treatment of anemia associated with chronic kidney disease: insights from clinical trials. Discov Med 1:147. https:\/\/doi.org\/10.1007\/s44337-024-00160-1","journal-title":"Discov Med"},{"key":"4501_CR109","doi-asserted-by":"publisher","first-page":"420","DOI":"10.34067\/KID.0000332020","volume":"1","author":"BP Concepcion","year":"2020","unstructured":"Concepcion BP, Forbes RC (2020) The role of telemedicine in kidney transplantation: opportunities and challenges. Kidney360 1:420\u2013423. https:\/\/doi.org\/10.34067\/KID.0000332020","journal-title":"Kidney360"},{"key":"4501_CR110","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ekir.2021.02.016","volume":"6","author":"S Lambooy","year":"2021","unstructured":"Lambooy S, Krishnasamy R, Pollock A et al (2021) Telemedicine for Outpatient Care of Kidney. Kidney Int Reports 6:1265\u20131272. https:\/\/doi.org\/10.1016\/j.ekir.2021.02.016","journal-title":"Kidney Int Reports"},{"key":"4501_CR111","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","volume":"99","author":"MG Shlipak","year":"2021","unstructured":"Shlipak MG, Tummalapalli SL, Boulware LE et al (2021) The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) Controversies Conference. Kidney Int 99:34\u201347. https:\/\/doi.org\/10.1016\/j.kint.2020.10.012","journal-title":"Kidney Int"},{"key":"4501_CR112","doi-asserted-by":"publisher","unstructured":"Yousef Almulhim M (2025) The efficacy of novel biomarkers for the early detection and management of acute kidney injury: A systematic review . PLoS One. 2025 Jan 29;20(1):e0311755. https:\/\/doi.org\/10.1371\/journal.pone.0311755","DOI":"10.1371\/journal.pone.0311755"},{"key":"4501_CR113","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12882-022-02837-0","volume":"23","author":"CK Cardol","year":"2022","unstructured":"Cardol CK, Boslooper-Meulenbelt K, Van Middendorp H et al (2022) Psychosocial barriers and facilitators for adherence to a healthy lifestyle among patients with chronic kidney disease: a focus group study. Bmc Nephrol 23:205","journal-title":"Bmc Nephrol"},{"key":"4501_CR114","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"4501_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2478\/cipms-2022-0019","volume":"35","author":"BK Durgaprasad","year":"2022","unstructured":"Durgaprasad BK, Malla RR, Lahari BD et al (2022) Role of predictable biomarkers in early detection of cardiovascular events in chronic kidney disease III and IV. Curr Issues Pharm Med Sci 35:99\u2013105. https:\/\/doi.org\/10.2478\/cipms-2022-0019","journal-title":"Curr Issues Pharm Med Sci"},{"key":"4501_CR116","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY-M et al (2022) Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol 18:696\u2013707","journal-title":"Nat Rev Nephrol"},{"key":"4501_CR117","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294\u20131304","journal-title":"JAMA"},{"key":"4501_CR118","doi-asserted-by":"publisher","first-page":"106329","DOI":"10.1016\/j.cmpb.2021.106329","volume":"209","author":"P Ventrella","year":"2021","unstructured":"Ventrella P, Delgrossi G, Ferrario G et al (2021) Supervised machine learning for the assessment of chronic kidney disease advancement. Comput Methods Progr Biomed 209:106329","journal-title":"Comput Methods Progr Biomed"},{"key":"4501_CR119","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41746-019-0104-2","volume":"2","author":"C-C Kuo","year":"2019","unstructured":"Kuo C-C, Chang C-M, Liu K-T et al (2019) Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learning. NPJ Digit Med 2:29","journal-title":"NPJ Digit Med"},{"key":"4501_CR120","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/HYPERTENSIONAHA.122.17944","volume":"79","author":"AR Chade","year":"2022","unstructured":"Chade AR, Bidwell GL III (2022) Novel drug delivery technologies and targets for renal disease. Hypertension 79:1937\u20131948","journal-title":"Hypertension"},{"key":"4501_CR121","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12882-020-01731-x","volume":"21","author":"EP Neale","year":"2020","unstructured":"Neale EP, Middleton J, Lambert K (2020) Barriers and enablers to detection and management of chronic kidney disease in primary healthcare: a systematic review. BMC Nephrol 21:83. https:\/\/doi.org\/10.1186\/s12882-020-01731-x","journal-title":"BMC Nephrol"},{"key":"4501_CR122","doi-asserted-by":"publisher","first-page":"e14157","DOI":"10.1111\/hex.14157","volume":"27","author":"DT Bulathwatta","year":"2024","unstructured":"Bulathwatta DT, Rudnik A, Bidzan M (2024) All good without anything good beyond survival: understanding the psychosocial experiences of individuals with chronic kidney disease and their caregivers in Sri Lanka. Heal Expect 27:e14157","journal-title":"Heal Expect"},{"key":"4501_CR123","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.xkme.2021.03.009","volume":"3","author":"JA Green","year":"2021","unstructured":"Green JA, Ephraim PL, Hill-Briggs F et al (2021) Integrated digital health system tools to support decision making and treatment preparation in CKD: the PREPARE NOW Study. Kidney Med 3:565-575.e1. https:\/\/doi.org\/10.1016\/j.xkme.2021.03.009","journal-title":"Kidney Med"},{"key":"4501_CR124","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.nefro.2024.01.005","volume":"44","author":"A Mata-Lima","year":"2024","unstructured":"Mata-Lima A, Paquete AR, Serrano-Olmedo JJ (2024) Remote patient monitoring and management in nephrology: a systematic review. Nefrologia 44:639\u2013667","journal-title":"Nefrologia"},{"key":"4501_CR125","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12916-024-03555-0","volume":"22","author":"S Stewart","year":"2024","unstructured":"Stewart S, Kalra PA, Blakeman T et al (2024) Chronic kidney disease: detect, diagnose, disclose\u2014a UK primary care perspective of barriers and enablers to effective kidney care. BMC Med 22:331","journal-title":"BMC Med"},{"key":"4501_CR126","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12875-024-02418-0","volume":"25","author":"E Pintado-Outumuro","year":"2024","unstructured":"Pintado-Outumuro E, Morin-Fraile V, Salvador-Gonz\u00e1lez B et al (2024) Exploring the factors influencing evidence-based approaches to advanced chronic kidney disease: a qualitative study involving nurses and physicians. BMC Prim Care 25:177","journal-title":"BMC Prim Care"},{"key":"4501_CR127","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40620-023-01838-y","volume":"37","author":"A Oude Engberink","year":"2024","unstructured":"Oude Engberink A, Tessier G, Kamil I et al (2024) General practitioners\u2019 representation of early-stage CKD is a barrier to adequate management and patient empowerment: a phenomenological study. J Nephrol 37:379\u2013390","journal-title":"J Nephrol"},{"key":"4501_CR128","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.akdh.2023.09.005","volume":"31","author":"L Cervantes","year":"2024","unstructured":"Cervantes L, Sinclair M, Camacho C et al (2024) Social and behavioral barriers to effective care during the transition to end-stage kidney care. Adv Kidney Dis Heal 31:21\u201327","journal-title":"Adv Kidney Dis Heal"},{"key":"4501_CR129","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000535864","volume":"55","author":"VA Luyckx","year":"2024","unstructured":"Luyckx VA, Elmaghrabi A, Sahay M et al (2024) Equity and quality of global chronic kidney disease care: what are we waiting for? Am J Nephrol 55:298\u2013315","journal-title":"Am J Nephrol"},{"key":"4501_CR130","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.14704\/NQ.2022.20.11.NQ66455","volume":"20","author":"S Sohi","year":"2022","unstructured":"Sohi S, Keshamma E, Butola K et al (2022) Gold nanoparticle sensors for monitoring chronic renal disease: applications of nanotechnology. NeuroQuantology 20:4464\u20134474. https:\/\/doi.org\/10.14704\/NQ.2022.20.11.NQ66455","journal-title":"NeuroQuantology"},{"key":"4501_CR131","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","volume":"81","author":"WR Zhang","year":"2019","unstructured":"Zhang WR, Parikh CR (2019) Biomarkers of acute and chronic kidney disease. Annu Rev Physiol 81:309\u2013333","journal-title":"Annu Rev Physiol"},{"key":"4501_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1177271920976146","volume":"15","author":"I Ali","year":"2020","unstructured":"Ali I, Ibrahim ST, Chinnadurai R et al (2020) A paradigm to discover biomarkers associated with chronic kidney disease progression. Biomark Insights 15:1\u20135. https:\/\/doi.org\/10.1177\/1177271920976146","journal-title":"Biomark Insights"},{"key":"4501_CR133","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","volume":"78","author":"JH Ix","year":"2021","unstructured":"Ix JH, Shlipak MG (2021) The promise of tubule biomarkers in kidney disease: a review. Am J Kidney Dis 78:719\u2013727. https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.026","journal-title":"Am J Kidney Dis"},{"key":"4501_CR134","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ckj\/sfac212","volume":"16","author":"S Copur","year":"2023","unstructured":"Copur S, Tanriover C, Yavuz F et al (2023) Novel strategies in nephrology: what to expect from the future? Clin Kidney J 16:230\u2013244. https:\/\/doi.org\/10.1093\/ckj\/sfac212","journal-title":"Clin Kidney J"},{"key":"4501_CR135","doi-asserted-by":"publisher","first-page":"E277","DOI":"10.1212\/WNL.0000000000207419","volume":"101","author":"A Dittrich","year":"2023","unstructured":"Dittrich A, Ashton NJ, Zetterberg H et al (2023) Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration: the H70 birth cohort study in Gothenburg. Neurology 101:E277\u2013E288. https:\/\/doi.org\/10.1212\/WNL.0000000000207419","journal-title":"Neurology"},{"key":"4501_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050773","author":"SC Valbuena-L\u00f3pez","year":"2023","unstructured":"Valbuena-L\u00f3pez SC, Camastra G, Cacciotti L et al (2023) Cardiac imaging biomarkers in chronic kidney disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom13050773","journal-title":"Biomolecules"},{"key":"4501_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.198","author":"RG Fassett","year":"2011","unstructured":"Fassett RG, Venuthurupalli SK, Gobe GC et al (2011) Biomarkers in chronic kidney disease\u202f: a review. Kidney Int. https:\/\/doi.org\/10.1038\/ki.2011.198","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04501-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04501-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:44:51Z","timestamp":1757155491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04501-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":139,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["4501"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04501-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}